Bausch + Lomb launches iPhone app

Article

Bausch + Lomb has introduced a free iPhone application that will test a patient's visual acuity and colour vision, enable them to learn more about cataracts and Crystalens and find a suitable surgeon.

Bausch + Lomb has introduced a free iPhone application that will test a patient's visual acuity and colour vision, enable them to learn more about cataracts and Crystalens and find a suitable surgeon.

The Crystalens iClear iPhone app features a "doc finder", offers a "Picture Hunt" game and provides information on other Bausch + Lomb Crystalens products.

The company claim the app, available in iPhone App Stores, will educate patients and surgeons alike on the significance of vision correction procedures.

The firm has also announced that it will offer Crystalens patients, who have received the implant in the US before 31 March 2011, a $250 rebate.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.